日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunotherapy targeting drug-tolerant Mycobacterium tuberculosis persisters accelerates tuberculosis cure in preclinical models.

针对耐药结核分枝杆菌持续感染者的免疫疗法可加速临床前模型中结核病的治愈。

Karanika Styliani, Wang Tianyin, Yilma Addis, Ruelas Castillo Jennie, Gordy James T, Bailey Hannah, Quijada Darla, Fessler Kaitlyn, Tasneen Rokeya, Rouse Salcido Elisa M, Shamma Farah, Harris Harley T, Chen Fengyixin, Bates Rowan E, Ton Heemee, Meza Jacob, Li Yangchen, Taylor Alannah D, Zheng Jean J, Zhang Jiaqi, Karantanos Theodoros, Maxwell Amanda R, Nuermberger Eric, Peske J David, Markham Richard B, Karakousis Petros C

J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of Pseudomonas Exotoxin A

J3ExoA:一种新型抗HIV免疫毒素,由抗Gp120 J3VHH和铜绿假单胞菌外毒素A的PE38片段融合而成。

Pincus, Seth H; Luo, Kun; Peters, Tami; Gordy, James T; Cole, Frances M; Klug, Grant; Ober, Kelli; Marcotte, Tamera K; Markham, Richard B

Novel Vaccines Targeting the Highly Conserved SARS-CoV-2 ORF3a Ectodomain Elicit Immunogenicity in Mouse Models.

针对高度保守的 SARS-CoV-2 ORF3a 胞外结构域的新型疫苗在小鼠模型中诱导免疫原性

Meza Jacob, Glass Elizabeth, Sandhu Avinaash K, Li Yangchen, Karanika Styliani, Fessler Kaitlyn, Hui Yinan, Schill Courtney, Wang Tianyin, Zhang Jiaqi, Bates Rowan E, Taylor Alannah D, Kapoor Aakanksha R, Ayeh Samuel K, Karakousis Petros C, Markham Richard B, Gordy James T

Brief Communication: Combination of an MIP3α-Antigen Fusion Therapeutic DNA Vaccine With Treatments of IFNα and 5-Aza-2'Deoxycytidine Enhances Activated Effector CD8+ T Cells Expressing CD11c in the B16F10 Melanoma Model

简讯:MIP3α-抗原融合治疗性DNA疫苗联合IFNα和5-氮杂-2'-脱氧胞苷治疗可增强B16F10黑色素瘤模型中表达CD11c的活化效应CD8+ T细胞

Fessler, Kaitlyn; Zhang, Jiaqi; Sandhu, Avinaash K; Hui, Yinan; Kapoor, Aakanksha R; Ayeh, Samuel K; Karanika, Styliani; Karakousis, Petros C; Markham, Richard B; Gordy, James T

Combination of a MIP3α-antigen fusion therapeutic DNA vaccine with treatments of IFNα and 5-Aza-2'Deoxycytidine enhances activated effector CD8+ T cells expressing CD11c in the B16F10 melanoma model

在B16F10黑色素瘤模型中,MIP3α-抗原融合治疗性DNA疫苗与IFNα和5-氮杂-2'-脱氧胞苷联合治疗可增强表达CD11c的活化效应CD8+ T细胞。

Fessler, Kaitlyn; Zhang, Jiaqi; Sandhu, Avinaash K; Hui, Yinan; Kapoor, Aakanksha R; Ayeh, Samuel K; Karanika, Styliani; Karakousis, Petros C; Markham, Richard B; Gordy, James T

IFNα and 5-Aza-2'-deoxycytidine combined with a dendritic-cell targeting DNA vaccine alter tumor immune cell infiltration in the B16F10 melanoma model

IFNα 和 5-氮杂-2'-脱氧胞苷联合靶向树突状细胞的 DNA 疫苗可改变 B16F10 黑色素瘤模型中的肿瘤免疫细胞浸润。

Gordy, James T; Sandhu, Avinaash K; Fessler, Kaitlyn; Luo, Kun; Kapoor, Aakanksha R; Ayeh, Samuel K; Hui, Yinan; Schill, Courtney; Chen, Fengyixin; Wang, Tianyin; Karanika, Styliani; Sunshine, Joel C; Karakousis, Petros C; Markham, Richard B

Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination

抗生素治疗塑造慢性结核感染期间的抗原环境,为治疗性疫苗接种提供新的靶点

Chuang, Yu-Min; Dutta, Noton K; Gordy, James T; Campodónico, Victoria L; Pinn, Michael L; Markham, Richard B; Hung, Chien-Fu; Karakousis, Petros C

Anti-IL-10-mediated Enhancement of Antitumor Efficacy of a Dendritic Cell-targeting MIP3α-gp100 Vaccine in the B16F10 Mouse Melanoma Model Is Dependent on Type I Interferons

在B16F10小鼠黑色素瘤模型中,抗IL-10介导的树突状细胞靶向MIP3α-gp100疫苗抗肿瘤疗效增强依赖于I型干扰素。

Gordy, James T; Luo, Kun; Francica, Brian; Drake, Charles; Markham, Richard B

Extended protection capabilities of an immature dendritic-cell targeting malaria sporozoite vaccine

针对疟疾子孢子疫苗的未成熟树突状细胞的延长保护能力

Luo, Kun; Zavala, Fidel; Gordy, James; Zhang, Hong; Markham, Richard B

Antiviral activity of a single-domain antibody immunotoxin binding to glycoprotein D of herpes simplex virus 2

单域抗体免疫毒素与单纯疱疹病毒2型糖蛋白D结合的抗病毒活性

Geoghegan, Eileen M; Zhang, Hong; Desai, Prashant J; Biragyn, Arya; Markham, Richard B